Jarislowsky, Fraser Ltd’s CME Group CME Stock Holding History

Jarislowsky, Fraser Ltd’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$47.3M	Sell	175,151 -3,858	-2%	-$1.05M	0.26%	63
2025 Q2	$49.3M	Sell	179,009 -22,603	-11%	-$6.15M	0.28%	62
2025 Q1	$53.5M	Sell	201,612 -22,267	-10%	-$5.49M	0.34%	60
2024 Q4	$52M	Buy	223,879 +1,819	+0.8%	+$418K	0.3%	58
2024 Q3	$49M	Buy	222,060 +16,468	+8%	+$3.41M	0.27%	61
2024 Q2	$40.4M	Buy	205,592 +48,672	+31%	+$10.1M	0.25%	64
2024 Q1	$33.8M	Buy	156,920 +3,050	+2%	+$641K	0.19%	68
2023 Q4	$32.4M	Buy	153,870 +5,623	+4%	+$1.2M	0.19%	68
2023 Q3	$29.7M	Buy	+148,247	New	+$29.5M	0.19%	66
2021 Q1	–	Sell	-2,525	Closed	-$459K	–	223
2020 Q4	$459K	Buy	2,525 +745	+42%	+$127K	﹤0.01%	187
2020 Q3	$297K	Hold	1,780	–	–	﹤0.01%	192
2020 Q2	$289K	Hold	1,780	–	–	﹤0.01%	194
2020 Q1	$307K	Hold	1,780	–	–	﹤0.01%	193
2019 Q4	$357K	Hold	1,780	–	–	﹤0.01%	197
2019 Q3	$376K	Sell	1,780 -36	-2%	-$7.52K	﹤0.01%	197
2019 Q2	$352K	Buy	1,816 +36	+2%	+$6.64K	﹤0.01%	198
2019 Q1	$292K	Buy	+1,780	New	+$315K	﹤0.01%	206

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Jarislowsky, Fraser Ltd's CME Position: Q3 2025 in Review

Jarislowsky, Fraser Ltd reduced its CME Group (CME) stake by 2.2% in Q3 2025, selling an estimated $1.05M and leaving 175,151 shares worth $47.3M. The position accounts for 0.26% of the portfolio, ranked #63.

Jarislowsky, Fraser Ltd first reported a position in CME in Q1 2019 and has held it in 17 quarters since. The position peaked at $53.5M in Q1 2025. 1,650 funds tracked by Wall St. Rank hold CME as of Q3 2025.

Jarislowsky, Fraser Ltd held 175,151 shares of CME Group worth $47.3M as of Q3 2025.
Jarislowsky, Fraser Ltd sold 3,858 CME Group shares in Q3 2025, an estimated $1.05M.
CME Group made up 0.26% of Jarislowsky, Fraser Ltd's portfolio in Q3 2025, its #63 holding.
Jarislowsky, Fraser Ltd first reported a position in CME Group in Q1 2019 and has held it in 17 quarters since.
Jarislowsky, Fraser Ltd's CME Group position peaked at $53.5M in Q1 2025.
1,650 funds tracked by Wall St. Rank held CME Group as of Q3 2025.

Based on Jarislowsky, Fraser Ltd's 13F filing for Q3 2025, filed 21 Oct 2025.